Literature DB >> 33422300

A population-based study of causes of death after endometrial cancer according to major risk factors.

Brittany Lees1, John M Hampton2, Amy Trentham-Dietz3, Polly Newcomb4, Ryan Spencer5.   

Abstract

OBJECTIVE: To identify the most common causes of death and potentially modifiable risk factors in endometrial cancer patients.
METHODS: 745 women diagnosed with incident endometrial cancer were enrolled in a population-based study from 1991 to 1994. Participants completed structured interviews about 1 year after diagnosis. Study files were linked with the National Death Index to identify dates and causes of death through 2016. Proportional hazards regression was used to estimate hazard rate ratios for cause of death adjusting for age and stage of disease. Hazard ratios were also examined according to comorbidities.
RESULTS: Of the 745 women, 450 were deceased after a median of 19.9 years. The two most common causes of death were cardiovascular disease (N = 145, 32%) and any cancer (N = 135, 30%), with only 10% of women dying from endometrial cancer (N = 46). Obesity, diabetes and smoking increased risk of all-cause mortality (HRR 1.77, 95%CI 1.36-2.31; HRR 1.74, 95%CI 1.34-2.27; HRR 1.59, 95%CI 1.16-2.17). Diabetes also increased risk of cardiovascular disease-specific mortality (HRR 1.98, 95%CI 1.38-3.08), but not endometrial cancer mortality (HRR 0.55, 95%CI 0.21-1.48). Neither obesity nor smoking was associated with increased risk of cardiovascular disease-specific mortality (HRR 1.46, 95%CI 0.92-2.32; HRR 1.21, 95%CI 0.67-2.18) nor endometrial-cancer specific mortality (HRR 1.81, 95%CI 0.83-3.93; HRR 0.61, 95%CI 0.17-2.15).
CONCLUSIONS: Endometrial cancer patients were 3 times more likely to die of cardiovascular disease than endometrial cancer. Obesity, smoking and diabetes increase the risk of death in these patients and are potentially modifiable. Clinical trials should be developed that incorporate counseling regarding these risk factors into survivorship care to determine impact on mortality.
Copyright © 2020. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2021        PMID: 33422300     DOI: 10.1016/j.ygyno.2020.12.020

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  4 in total

1.  Prospective Cohort Study of Pre- and Postdiagnosis Obesity and Endometrial Cancer Survival.

Authors:  Renée L Kokts-Porietis; Jessica McNeil; Andria R Morielli; Linda S Cook; Kerry S Courneya; Christine M Friedenreich
Journal:  J Natl Cancer Inst       Date:  2022-03-08       Impact factor: 11.816

Review 2.  A Review on CYP11A1, CYP17A1, and CYP19A1 Polymorphism Studies: Candidate Susceptibility Genes for Polycystic Ovary Syndrome (PCOS) and Infertility.

Authors:  Roozbeh Heidarzadehpilehrood; Maryam Pirhoushiaran; Rasoul Abdollahzadeh; Malina Binti Osman; Maryam Sakinah; Norshariza Nordin; Habibah Abdul Hamid
Journal:  Genes (Basel)       Date:  2022-02-05       Impact factor: 4.096

3.  Survival outcomes in endometrial cancer patients according to diabetes: a systematic review and meta-analysis.

Authors:  Lauren McVicker; Christopher R Cardwell; Lauren Edge; W Glenn McCluggage; Declan Quinn; James Wylie; Úna C McMenamin
Journal:  BMC Cancer       Date:  2022-04-20       Impact factor: 4.638

Review 4.  Prevention of endometrial cancer through lifestyle Interventions: A systematic review and synthesis.

Authors:  Dayle Rundle-Thiele; Sujal Shrestha; Monika Janda
Journal:  Gynecol Oncol Rep       Date:  2021-12-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.